Patent · US Expired

Method, assay, and kit for quantifying HIV protease inhibitors

US6821744B2 · kind B2 · utility

0Cited by

7References

42Claims

0Family size

Assignee

Roche Diagnostics Operations, Inc. · US

Inventors

Herbert von der Eltz · Spaichingen, DE
Lili Arabshahi · Fremont, US
Haijuan Li · 安丰镇, CN
Erasmus Huber · Garching bei München, DE

Key dates

Filing date	Oct 29, 2002
Grant date	Nov 23, 2004
Priority date	—
Expiry date	Oct 29, 2022

Classification

Technology area (CPC Y)Emerging Cross-Sectional Technologies
CPC primaryY10S435/81
WIPO fieldMeasurement
WIPO sectorInstruments

Abstract

A method for quantifying an HIV protease inhibitor in a sample includes combining HIV protease, a conjugate comprising an HIV protease inhibitor analog, and a sample suspected of containing an HIV protease inhibitor. The HIV protease and the conjugate are capable of forming a detectable complex. The method also includes measuring the amount of the detectable complex, and relating the amount of the detectable complex to a concentration of the HIV protease inhibitor in the sample.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.